HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Melany, M. L. Articles by Kimme-Smith, C. Search for Related Content PubMed PubMed Citation Articles by Melany, M. L. Articles by Kimme-Smith, C.

Effect of US Contrast Agents on Spectral Velocities: In Vitro Evaluation¹

¹ From the Department of Radiological Sciences, University of California, Los Angeles, Medical Center, 10833 Le Conte Ave, M/C 172115, Los Angeles, CA 90095-1721 (M.L.M., S.F., D.M., C.K.S.), and the Department of Radiology, West Los Angeles Veterans Affairs Medical Center, Los Angeles, Calif (E.G.G.). Received June 10, 1998; revision requested July 27; revision received August 17; accepted October 14. Address reprint requests to M.L.M.

PURPOSE: To evaluate the effect of ultrasonographic (US) contrast agents on measurements of peak velocity with spectral Doppler US in stenotic and nonstenotic flow states.

MATERIALS AND METHODS: Nonpulsatile flow was established in a flow phantom with 0%, 50%, 75%, and 90% stenoses. SH U 508A, perflenapent emulsion, and perfluorohexane emulsion were the contrast agents evaluated. Before and after administration of each contrast agent, two peak velocity measurements obtained proximal to, at the site of, and distal to the stenosis in each vessel model were averaged. The percentage difference in peak velocity after contrast agent administration was calculated for each site interrogated. The mean, SD, and coefficient of variation of the percentage difference in peak velocity were calculated.

RESULTS: Percentage differences in peak velocity after contrast agent administration at different sample volume sites were not significantly different irrespective of the degree of stenosis or the contrast agent evaluated.

CONCLUSION: The contrast agents evaluated do not produce a statistically significant increase in peak velocity. If this result is corroborated in clinical practice, contrast agents can be used without reevaluating existing Doppler US thresholds for stenosis.

Index terms: Blood, flow dynamics, 9_*.12984² • Blood vessels, stenosis or obstruction, 9_*.721 • Ultrasound (US), contrast media, 9_*.12988 • Ultrasound (US), Doppler studies, 9_*.12984

This article has been cited by other articles:

				G. Deklunder Role of ultrasound and contrast-enhanced ultrasound in patients with cerebrovascular disease Eur. Heart J. Suppl., March 1, 2002; 4(suppl_C): C51 - C55. [Abstract] [PDF]

				M. Rohrberg and R. Brodhun Measurement of Vasomotor Reserve in the Transcranial Doppler-CO2 Test Using an Ultrasound Contrast Agent (Levovist) Stroke, June 1, 2001; 32(6): 1298 - 1303. [Abstract] [Full Text] [PDF]